Exploring the detection of AQNs in large liquid detectors von Lazanu, I., Parvu, M.

Volltext

Radioactive background for ProtoDUNE detector von Parvu, M., Lazanu, I.

Volltext

Large low background kTon-scale liquid argon time projection chambers von Bezerra, T, Borkum, A, Church, E, Djurcic, Z, Genovesi, J, Haiston, J, Jackson, C M, Lazanu, I, Monreal, B, Munson, S, Ortiz, C, Parvu, M, Peeters, S J M, Pershey, D, Poudel, S S, Reichenbacher, J, Saldanha, R, Scholberg, K, Sinev, G, Westerdale, S, Zennamo, J

Volltext

Rheumatoid arthritis and atherosclerosis: Why is important to evaluate this? von Parvu, M, Coman, S, Voidazan, S

Volltext

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort a... von Dima, A, Vonk, MC, Garaiman, A, Kersten, BE, Becvar, R, Tomcik, M, Hoffmann-Vold, A-M, Castellvi, I, Jaime, JL Tandaipan, Brzosko, M, Milchert, M, Krasowska, D, Michalska-Jakubus, M, Airo, P, Matucci-Cerinic, M, Bruni, C, Iudici, M, Distler, JHW, Gheorghiu, AM, Poormoghim, H, Motta, F, De Santis, M, Parvu, M, Distler, O, Mihai, C

Volltext

FRI0166 Persistence of Biologic Therapy for Patients with Active Rheumatoid Arthritis: Data from The Romanian Registry of Rheumatic Diseases von Codreanu, C., Mogosan, C., Parvu, M., Rednic, S., Ionescu, R.

Volltext

Cardiovascular risk was not influenced by the use of statins in a cohort rheumatoid arthritis patients that undergone effective biologic treatment von Opris, D, Mazilu, D, Parvu, M, Ionescu, R

Volltext

Subclinical atherosclerosis in patients with rheumatoid arthritis- challenges in diagnosis and treatments von Parvu, M, Szasz, S, Opris, D

Volltext

Treatments used in rheumatoid arthritis and their influence on subclinical atherosclerosis von Parvu, M, Fit, L, Voidazan, S

Volltext

FRI0171 Evaluating Treatment Efficacy in Rheumatoid Arthritis: Interrelation Disease Activity – Functional Status – Utility von Mogosan, C., Codreanu, C., Enache, L., Parvu, M., Rednic, S., Ionescu, R.

Volltext

Low plasma paraoxonase-1 level found in a cohort of primary Sjogren's Syndrome patients von Opris, D, Parvu, M, Corneteanu, R. Sfrent, Munteanu, E, Ionescu, R

Volltext

Atherosclerosis and psoriatic arthritis: Can we prevent this? von Parvu, M, Coman, S, Voidazan, S, Szasz, S, Sigmirean, M, Opris, D

Volltext

FRI0424 Accessibility To Biological Therapy for Patients with Ankylosing Spondylitis in Romania Is Influenced by Area of Residence, Socio- Economic and Demographic Factors von Enache, L., Codreanu, C., Mogosan, C., Gutoiu, G., Popescu, C., Parvu, M., Rednic, S., Ionescu, R.

Volltext

THU0163 Disease Flares Predict the Change to Second Line Therapy in Rheumatoid Arthritis: 9-Year Data from a Longitudinal Observational Study von Ancuta, I., Codreanu, C., Ionescu, R., Parvu, M., Bojinca, M.

Volltext

THU0106 Rituximab after first anti-TNF failure is more efficient with high impact in reducing time and costs to achieve superior rates of low disease activity and remission von Ancuta, I., Codreanu, C., Ionescu, R., Parvu, M., Bojinca, M.

Volltext

OP0026 Sustained and cumulated response over time in ra patients treated with rituximab after initial failure of anti-TNF agents von Ancuta, I., Codreanu, C., Ionescu, R., Parvu, M., Bojinca, M.

Volltext

AB0537 Superior low disease activity and remission rates when rituximab is initiated after the first anti-TNF failure: Real life data von Ancuta, I., Codreanu, C., Ionescu, R., Parvu, M., Bojinca, M.

Volltext

THU0162 Patterns of Clinical Response Predict Failure of TNF Inhibitor Treatment in Rheumatoid Arthritis: Data from a Longitudinal Observational Study in Romania von Ancuta, I., Codreanu, C., Ionescu, R., Parvu, M., Bojinca, M.

Volltext

THU0431 Area of Residence and Socio-Economic Factors Significantly Affect ACCESS to Biological Therapy for Rheumatoid Arthritis Patients in Romania von Codreanu, C., Mogosan, C., Ionescu, R., Ancuta, I., Parvu, M., Rednic, S.

Volltext

FRI0107 Romanian Registry of Rheumatic Diseases: Efficacy and Safety of Biologic Therapy in Rheumatoid Arthritis von Codreanu, C., Mogosan, C., Enache, L., Stanciu, D., Ionescu, R., Opris, D., Rednic, S., Parvu, M.

Volltext